Related Experiment Video

Updated: Jun 8, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Improving evidence-based care in cystic fibrosis through quality improvement

Gary L McPhail1, Jeanne Weiland, James D Acton

  • 1Division of Pulmonary Medicine, University of Cincinnati, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio 45229-3039, USA. gary.mcphail@cchmc.org

Archives of Pediatrics & Adolescent Medicine
|October 6, 2010
PubMed

Insights

Improving clinician adherence to cystic fibrosis (CF) medication guidelines is achievable. Educating providers and families, alongside monitoring, significantly boosts adherence to evidence-based recommendations for pediatric CF care.

Area of Science:

  • Pediatric Pulmonology
  • Clinical Quality Improvement
  • Evidence-Based Medicine

Background:

  • Cystic Fibrosis (CF) management requires adherence to specific pulmonary medication guidelines.
  • Variability in clinician prescribing practices can impact patient outcomes in CF.

Purpose of the Study:

  • To enhance clinician adherence to established prescribing guidelines for pulmonary medications in pediatric patients with CF.
  • To implement and evaluate a quality improvement initiative targeting medication prescribing in CF.

Main Methods:

  • A quality improvement project utilizing a multiple time series design was conducted at a US tertiary care pediatric hospital.
  • Interventions included developing evidence-based guidelines, educating clinicians and families, and implementing a monitoring system with accountability measures.
  • Adherence was tracked via a CF database and record reviews for children eligible for azithromycin, dornase alfa, or inhaled tobramycin.

Main Results:

  • Initial clinician adherence to prescribing guidelines was 62% among 170 pediatric CF patients.
  • After 3 months, adherence increased to 87% (OR=4.6, 95% CI: 3.0-7.0).
  • This improvement in adherence was sustained over 21 months of follow-up.

Conclusions:

  • Educating clinicians on prescribing guidelines is crucial for improving adherence.
  • Engaging families by sharing guidelines enhances the effectiveness of adherence interventions.
  • Continuous monitoring and accountability mechanisms are key to sustaining improved prescribing practices in CF care.
Abstract

More Related Videos

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis07:16

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis

Published on: September 20, 2024

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression08:58

Cystic Fibrosis Aggregate Biofilm Model to Study Infection-relevant Gene Expression

Published on: April 18, 2025

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chest Physiotherapy01:24

Chest Physiotherapy

Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History